Wilding IR - Search Results

1

Combined scintigraphic and pharmacokinetic investigation of enteric-coated mesalazine micropellets in healthy subjects.

Wilding IR, Behrens C, Tardif SJ, Wray H, Bias P, Albrecht W. Wilding IR, et al. Aliment Pharmacol Ther. 2003 May 1;17(9):1153-62. doi: 10.1046/j.1365-2036.2003.01558.x. Aliment Pharmacol Ther. 2003. PMID: 12752352 Clinical Trial.

2

In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.

Wilding IR, Hardy JG, Sparrow RA, Davis SS, Daly PB, English JR. Wilding IR, et al. Pharm Res. 1992 Nov;9(11):1436-41. doi: 10.1023/a:1015858829187. Pharm Res. 1992. PMID: 1475230 Clinical Trial.

3

Colonic spreading of a non-chlorofluorocarbon mesalazine rectal foam enema in patients with quiescent ulcerative colitis.

Wilding IR, Kenyon CJ, Chauhan S, Hooper G, Marshall S, McCracken JS, Staab HJ, Armbrecht J. Wilding IR, et al. Aliment Pharmacol Ther. 1995 Apr;9(2):161-6. doi: 10.1111/j.1365-2036.1995.tb00365.x. Aliment Pharmacol Ther. 1995. PMID: 7605856

4

Targeting of drugs and vaccines to the gut.

Wilding IR, Davis SS, O'Hagan DT. Wilding IR, et al. Pharmacol Ther. 1994 Apr-May;62(1-2):97-124. doi: 10.1016/0163-7258(94)90006-x. Pharmacol Ther. 1994. PMID: 7991649 Review.

5

Localization of drug release sites from an oral sustained-release formulation of 5-ASA (Pentasa) in the gastrointestinal tract using gamma scintigraphy.

Hardy JG, Harvey WJ, Sparrow RA, Marshall GB, Steed KP, Macarios M, Wilding IR. Hardy JG, et al. Among authors: wilding ir. J Clin Pharmacol. 1993 Aug;33(8):712-8. doi: 10.1002/j.1552-4604.1993.tb05612.x. J Clin Pharmacol. 1993. PMID: 8408731

6

The use of scintigraphy to provide "proof of concept" for novel polysaccharide preparations designed for colonic drug delivery.

Adkin DA, Kenyon CJ, Lerner EI, Landau I, Strauss E, Caron D, Penhasi A, Rubinstein A, Wilding IR. Adkin DA, et al. Among authors: wilding ir. Pharm Res. 1997 Jan;14(1):103-7. doi: 10.1023/a:1012019820603. Pharm Res. 1997. PMID: 9034229 Clinical Trial.

7

Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation.

Kenyon CJ, Nardi RV, Wong D, Hooper G, Wilding IR, Friend DR. Kenyon CJ, et al. Among authors: wilding ir. Aliment Pharmacol Ther. 1997 Feb;11(1):205-13. doi: 10.1046/j.1365-2036.1997.93265000.x. Aliment Pharmacol Ther. 1997. PMID: 9042995 Clinical Trial.

8

Colonic spread of three rectally administered mesalazine (Pentasa) dosage forms in healthy volunteers as assessed by gamma scintigraphy.

Brown J, Haines S, Wilding IR. Brown J, et al. Among authors: wilding ir. Aliment Pharmacol Ther. 1997 Aug;11(4):685-91. doi: 10.1046/j.1365-2036.1997.00193.x. Aliment Pharmacol Ther. 1997. PMID: 9305476 Clinical Trial.

9

Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet.

Wilding IR, Kenyon CJ, Hooper G. Wilding IR, et al. Aliment Pharmacol Ther. 2000 Feb;14(2):163-9. doi: 10.1046/j.1365-2036.2000.00696.x. Aliment Pharmacol Ther. 2000. PMID: 10651656 Clinical Trial.

10

The role of gamma-scintigraphy in oral drug delivery.

Wilding IR, Coupe AJ, Davis SS. Wilding IR, et al. Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):103-24. doi: 10.1016/s0169-409x(00)00135-6. Adv Drug Deliv Rev. 2001. PMID: 11259836 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters